High Growth Tech Stocks To Watch In Europe June 2025
As the European markets experience a boost, with the STOXX Europe 600 Index climbing by 0.90% amid easing inflation and supportive monetary policy from the European Central Bank, investors are increasingly focusing on high-growth sectors such as technology. In this environment, identifying promising tech stocks involves looking for companies that can leverage favorable economic conditions and technological advancements to drive substantial growth.
Name
Revenue Growth
Earnings Growth
Growth Rating
Intellego Technologies
30.80%
45.66%
★★★★★★
Archos
21.07%
36.58%
★★★★★★
KebNi
21.51%
66.96%
★★★★★★
Pharma Mar
29.61%
44.92%
★★★★★★
Bonesupport Holding
29.14%
56.14%
★★★★★★
argenx
21.50%
26.61%
★★★★★★
Skolon
31.51%
99.52%
★★★★★★
Xbrane Biopharma
24.95%
56.77%
★★★★★★
Diamyd Medical
86.29%
93.04%
★★★★★★
Elliptic Laboratories
36.33%
78.99%
★★★★★★
Click here to see the full list of 226 stocks from our European High Growth Tech and AI Stocks screener.
Let's explore several standout options from the results in the screener.
Simply Wall St Growth Rating: ★★★★★★
Overview: argenx SE is a commercial-stage biopharma company focused on developing therapies for autoimmune diseases across several countries including the United States, Japan, China, and the Netherlands, with a market cap of €31.52 billion.
Operations: argenx focuses on developing therapies for autoimmune diseases, generating revenue primarily from its biotechnology segment, which reported $2.64 billion. The company's operations span multiple countries, including the United States, Japan, China, and the Netherlands.
argenx SE has demonstrated remarkable growth with a surge in revenue to $807.37 million, doubling from the previous year's $412.51 million, alongside transitioning from a net loss to a substantial net income of $169.47 million. This financial turnaround is underscored by robust R&D commitments, crucial for sustaining innovation and competitiveness in the biotech landscape. The firm's recent CHMP nod for VYVGART® in CIDP treatment further highlights its strategic focus on expanding therapeutic applications, promising continued relevance and impact within the healthcare sector.
Click here to discover the nuances of argenx with our detailed analytical health report.
Understand argenx's track record by examining our Past report.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Believe S.A. is a company that offers digital music services to independent labels and local artists across various regions including France, Germany, the rest of Europe, the Americas, Asia, Oceania, and the Pacific with a market cap of approximately €1.72 billion.
Operations: The company's revenue primarily comes from Premium Solutions, generating €924.24 million, while Automated Solutions contribute €64.59 million.
Believe, a European tech entity, is navigating its path towards profitability with expected earnings growth of 96.9% annually. Despite current unprofitability, its revenue growth outpaces the French market's average at 13.4% per year compared to 5%. This growth trajectory is supported by strategic moves such as the proposed acquisition by TCMI Inc., EQT X, and Denis Ladegaillerie for a €57.9 million stake, enhancing financial stability and market presence. Moreover, Believe's commitment to R&D aligns with industry demands for continuous innovation, ensuring it remains competitive in the dynamic tech landscape.
Get an in-depth perspective on Believe's performance by reading our health report here.
Examine Believe's past performance report to understand how it has performed in the past.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Comet Holding AG, along with its subsidiaries, delivers X-ray and radio frequency (RF) power technology solutions globally across Europe, North America, and Asia, with a market capitalization of CHF1.79 billion.
Operations: The company generates revenue through three main segments: X-Ray Systems (CHF115.89 million), Industrial X-Ray Modules (CHF94.57 million), and Plasma Control Technologies (CHF247.39 million).
Comet Holding AG, a Swiss tech firm, is making notable strides with an earnings growth of 37.3% annually, significantly outpacing the local market's average of 10.7%. This robust performance is further underscored by its revenue increase of 12.2% per year, which also surpasses the Swiss market growth rate of 4.2%. Notably, Comet's commitment to innovation is evident in its R&D spending, crucial for maintaining technological leadership in a competitive sector. Recent corporate actions include electing Benjamin Loh as Chairman and approving a dividend increase to CHF 1.50 per share, signaling strong governance and shareholder confidence amidst a promising financial trajectory marked by first-quarter sales surging by 37.5% year-over-year to CHF 111.2 million.
Take a closer look at Comet Holding's potential here in our health report.
Assess Comet Holding's past performance with our detailed historical performance reports.
Dive into all 226 of the European High Growth Tech and AI Stocks we have identified here.
Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.
Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ENXTBR:ARGX ENXTPA:BLV and SWX:COTN.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
Yili Secures Four World Dairy Innovation Awards at the 18th Global Dairy Congress
AMSTERDAM, June 23, 2025 /PRNewswire/ -- On June 18–19, the Global Dairy Congress 2025 was held in Amsterdam. At the forum, Dr. Ignatius Szeto, Assistant President of Yili Group, delivered a keynote speech titled "Innovating for a sustainable future" and shared Yili's latest innovative practices. On the opening day, the organizers unveiled the winners of the 2025 World Dairy Innovation Awards. Yili secured four World Dairy Innovation Awards and six commended Awards. Notably, Yili has claimed the World Dairy Innovation Awards for six consecutive years. Dr. Carolien van Loo, Head of Yili Innovation Center Europe, attended a roundtable forum on maternal and infant nutrition and breast milk research. Multiple star products from Yili's top infant formula brand, Pro-Kido, were featured as the Congress's officially designated products. At the Industry Leadership Forum, Dr. Ignatius Szeto systematically introduced Yili's global innovation practices across product innovation, maternal and infant nutrition, advanced dairy processing, and sustainable development. He emphasized: "Innovation is the driving force behind the sustainable prosperity of the dairy industry. Remaining consumer-centric, Yili dedicates itself to nutrition and health research across the full life cycle, keeps making core technological breakthroughs, and accelerates the commercialization of fundamental research outcomes—all of which contribute to the advancement of the global dairy sector." During the roundtable forum themed "Innovation in Pioneering a New Future for Global Maternal and Infant Health", Dr. Ignatius Szeto and Dr. Carolien van Loo engaged in in-depth discussions with experts including Jean-Christophe Kremer, Secretary-General of the International Special Dietary Foods Industries, and Richard Hall, Chair of FoodBev Media. The discussions focused on research about breast milk and maternal and infant nutrition. Dr. Carolien van Loo highlighted that Yili Innovation Center Europe, in collaboration with institutions such as Wageningen University and Donders Institute for Brain, Cognition and Behaviour, has conducted pioneering research on HMOs. Their breakthrough findings demonstrated HMOs' health benefits in enhancing immunity, protecting gut barrier function, preventing pathogen adhesion, and promoting cognitive development. The annual World Dairy Innovation Awards were announced at the event. This year, Yili Group secured four awards for its high-quality products and outstanding performance in innovation. Zhenlao Light Cream from Yijiahao Cheese won the Best Artisan Product, Joyday Crunchy Choco Lava was awarded Best Ice Cream, Yili's patented multi-enzymatic lactose-to-GOS technology: Boosting Gut Health in Qinghuo Adult Milk Powder claimed the Best Intolerance-Friendly Innovation, and Satine Carbon-Reduced Organic Milk won the Best CSR/Sustainability Initiative. Staying true to its philosophy of "No Innovation, No Future," Yili consistently increases its R&D investment to provide comprehensive nutrition solutions for consumers across the full life cycle. To date, Yili has established 15 innovation centers across Asia, Europe, and Oceania. Moving forward, Yili will continue to align its strategy with consumer needs, drive growth through technological innovation, and foster global partnerships to deliver enhanced health value for consumers worldwide, aiming to enable the sustainable prosperity of the dairy industry. View original content to download multimedia: SOURCE Yili Group Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
29 minutes ago
- Yahoo
Undiscovered Gems in Europe for June 2025
As European markets navigate through a landscape marked by tensions in the Middle East and varying inflation pressures, the pan-European STOXX Europe 600 Index recently saw a decline of 1.54%, reflecting broader concerns impacting investor sentiment. Amid these challenges, discerning investors might find opportunities in small-cap stocks that demonstrate resilience and potential for growth, particularly those with strong fundamentals and innovative business models tailored to adapt to evolving economic conditions. Name Debt To Equity Revenue Growth Earnings Growth Health Rating AB Traction NA 5.39% 5.24% ★★★★★★ Caisse Régionale de Crédit Agricole Mutuel Brie Picardie Société coopérative 26.90% 4.14% 7.22% ★★★★★★ Martifer SGPS 102.88% -0.23% 7.16% ★★★★★★ Linc NA 101.28% 29.81% ★★★★★★ ABG Sundal Collier Holding 8.55% -4.14% -12.38% ★★★★★☆ Caisse Regionale de Credit Agricole Mutuel Toulouse 31 19.46% 0.47% 7.14% ★★★★★☆ Alantra Partners 3.79% -3.99% -23.83% ★★★★★☆ Dekpol 63.20% 11.06% 13.37% ★★★★★☆ Castellana Properties Socimi 53.49% 7.49% 44.78% ★★★★☆☆ Evergent Investments 5.39% 9.41% 21.17% ★★★★☆☆ Click here to see the full list of 336 stocks from our European Undiscovered Gems With Strong Fundamentals screener. Let's dive into some prime choices out of from the screener. Simply Wall St Value Rating: ★★★★☆☆ Overview: Waberer's International Nyrt. offers transportation, forwarding, and logistics services across Europe and internationally, with a market cap of €218.85 million. Operations: The company generates revenue primarily from its insurance segment, which contributes €98.17 million. A notable financial aspect is the segment adjustment amounting to €659.39 million. Waberer's International Nyrt. has shown robust earnings growth of 38.6% over the past year, outperforming the transportation industry, which saw a -13.5% change. The company's net income for Q1 2025 was €7.5M, a significant jump from €1.1M in the previous year, reflecting improved profitability despite sales slightly decreasing to €194.4M from €196.7M last year. The debt-to-equity ratio rose to 62.6% over five years; however, interest payments remain well-covered by EBIT at 7.9x coverage and more cash than total debt suggests financial stability amidst these changes. Click to explore a detailed breakdown of our findings in Waberer's International Nyrt's health report. Examine Waberer's International Nyrt's past performance report to understand how it has performed in the past. Simply Wall St Value Rating: ★★★★★★ Overview: BTS Group AB (publ) is a professional services firm with a market capitalization of approximately SEK4.25 billion. Operations: The company generates revenue primarily from its BTS North America segment with SEK1.56 billion, followed by BTS Other Markets and BTS Europe at SEK838.95 million and SEK631.37 million respectively. Additionally, Advantage Performance Group contributes SEK142.19 million to the overall revenue stream. BTS Group, a smaller player in the professional services sector, has shown impressive earnings growth of 46% over the past year, outpacing the industry's 12%. Despite a large one-off gain of SEK167.5M affecting recent results, its debt-to-equity ratio improved slightly from 26.9% to 26.3% in five years. Trading at a significant discount of 57.5% below estimated fair value and having more cash than total debt enhances its appeal. However, net income for Q1 dropped to SEK25.73 million from SEK53.3 million last year, indicating potential volatility ahead despite revenue forecasts suggesting steady growth at about 6.7%. BTS Group's integration of AI technologies aims to enhance operational efficiency and diversify revenue streams; click here to explore the full narrative on the company's potential. Simply Wall St Value Rating: ★★★★★★ Overview: RaySearch Laboratories AB (publ) is a medical technology company that develops software solutions for cancer treatment globally, with a market cap of SEK10.78 billion. Operations: RaySearch Laboratories generates revenue primarily from its healthcare software segment, totaling SEK1.27 billion. It focuses on developing software solutions for cancer treatment worldwide. RaySearch Labs, a nimble player in medical technology, is making strides with its innovative software solutions for cancer treatment. The company has seen earnings soar by 122% over the past year, outpacing the healthcare services industry. With no debt on its books compared to a 24.9% debt-to-equity ratio five years ago, RaySearch stands financially robust. Recent upgrades to their RayStation and RayCare systems aim to streamline adaptive treatment planning through AI integration. However, challenges like exchange rate volatility and regulatory hurdles could impact growth despite projected annual revenue increases of 13.9%. RaySearch Laboratories is leveraging AI and new modules for potential growth. Click here to explore the full narrative on RaySearch's strategic advancements and market opportunities. Discover the full array of 336 European Undiscovered Gems With Strong Fundamentals right here. Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance. Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BST:3WB OM:BTS B and OM:RAY B. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
35 minutes ago
- Yahoo
'We are not a killer': Amazon sees future for high street retail hand in hand with e-commerce
Amazon VP Mariangela Marseglia discusses 'The Everything Store' and the major trends hitting the retail industry right now. View on euronews Sign in to access your portfolio
